CSCRMi001-A

Registration Summary:

A P E C

POGLUT1 D233E - II.5-1

The cell line is not submitted yet.

(only basic data is shown)

General#

Cell Line
hPSCreg Name	CSCRMi001-A
Alternative name(s)	POGLUT1 D233E - II.5-1
Cell line type	Human induced pluripotent stem cell (hiPSC)
Last update	11th February 2019
User feedback	Written by on No feedback available yet. Login to share your feedback, experiences or results with the research community.
Provider
Generator	Center for Stem Cell and Regenerative Medicine (CSCRM) / University of Texas Health Science Center at Houston (UTHealth) (CSCRM)
External Databases
Cellosaurus	CVCL_QX93
General Information
Publications	Rehakova D.. Standardized hiPSCs culture – vitronectin coating for cGMP compliant protocol. . 2017-01-01. Wu J et al. Generation of an induced pluripotent stem cell line (CSCRMi001-A) from a patient with a new type of limb-girdle muscular dystrophy (LGMD) due to a missense mutation in POGLUT1 (Rumi). Stem cell research. 2017 Oct;24:102-105. Xia G et al. Human iPSC Models to Study Orphan Diseases: Muscular Dystrophies. Current stem cell reports. 2018;4(4):299-309. Xia G et al. Human iPSC Models to Study Orphan Diseases: Muscular Dystrophies. Curr Stem Cell Rep. 2018-10-04. Angelini C et al. Advances in imaging of brain abnormalities in neuromuscular disease. Therapeutic advances in neurological disorders. 2019;12:1756286419845567. Min YL et al. CRISPR Correction of Duchenne Muscular Dystrophy. Annual review of medicine. 2019 Jan 27;70:239-255. Rajaei S et al. Meeting Between Rumi and Shams in Notch Signaling; Implications for Pain Management: A Narrative Review. Anesthesiology and pain medicine. 2019 Feb;9(1):e85279. Uniyal AP et al. An overview of designing and selection of sgRNAs for precise genome editing by the CRISPR-Cas9 system in plants. 3 Biotech. 2019 Jun;9(6):223.

hIPSC Derivation#

General